Clinical Trials
4 trialsNCT07612930 2026-05-29
Expanded Access to PCNAT-01 for Patients With Resected Pancreatic Ductal Adenocarcinoma Following Surgical Resection and Adjuvant Therapy
Anda Biopharmaceutical Development (Shenzhen) Co., Ltd.
Available
NCT07301229 2025-12-24
A Phase II Clinical Study to Evaluate HLX43 in Subjects With Advanced Pancreatic Cancer
Shanghai Henlius Biotech
Phase 2 Not yet recruiting
NCT06182072 2025-10-01
ProAgio in Pancreatic Ductal Adenocarcinoma (PDAC)
ProDa BioTech, LLC
Phase 1 Recruiting
NCT06481397 2025-07-02
OSCAR I STUDY - The ONCObind CTC Removal Study
ExThera Medical Corporation
Phase NA Completed